ScholarIQanswers from OpenAlex & ORCID
I‐Wei Chang
ResearcherPublications, citations & collaboration network
I‐Wei Chang is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does I‐Wei Chang have?
ScholarIQindexed works
I‐Wei Chang has 104 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does I‐Wei Chang have?
ScholarIQcitation count
I‐Wei Chang has 1,255 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of I‐Wei Chang?
ScholarIQh-index
I‐Wei Chang has an h-index of 22 in OpenAlex.
What is the i10-index of I‐Wei Chang?
ScholarIQi10-index
I‐Wei Chang has an i10-index of 42 in OpenAlex.
What is the ORCID of I‐Wei Chang?
ScholarIQorcid
The ORCID for I‐Wei Chang is on the source record.
What is the OpenAlex record for I‐Wei Chang?
ScholarIQopenalex
The OpenAlex for I‐Wei Chang is on the source record.
What are the most-cited papers on I‐Wei Chang?
ScholarIQmost cited works
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao‐Chun Hsu, Vithika Suri, Mindie H. Nguyen, Yen‐Tsung Huang, Chi-Yi Chen, I‐Wei Chang, Cheng‐Hao Tseng, Chun‐Ying Wu, Jaw‐Town Lin, David Z. Pan, Anuj Gaggar, Ondřej Podlaha
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
I‐Wei Chang, Victor C. Lin, Hong-Lin He, Chao‐Tien Hsu, Ching‐Chia Li, Wen‐Jeng Wu, Chun‐Nung Huang, Tingfeng Wu, Chien‐Feng Li
Melanotic Xp11 Translocation Renal Cancer
I‐Wei Chang, Hsuan‐Ying Huang, Ming-Tse Sung
Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial
Yao‐Chun Hsu, Chi-Yi Chen, I‐Wei Chang, Chi‐Yang Chang, Chun‐Ying Wu, Teng‐Yu Lee, Ming‐Shiang Wu, Ming‐Jong Bair, Jyh-Jou Chen, Chieh‐Chang Chen, Cheng‐Hao Tseng, Chi‐Ming Tai, Yen‐Tsung Huang, Wen‐Hui Ku, Lein‐Ray Mo, Jaw‐Town Lin
The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy
Ying-En Lee, Hong-Lin He, Yow‐Ling Shiue, Sung‐Wei Lee, Li‐Ching Lin, Tingfeng Wu, I‐Wei Chang, Hao‐Hsien Lee, Chien‐Feng Li